{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:06:44Z","timestamp":1789646804872,"version":"4.0.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/ftd.0b013e318228bb2a","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T17:49:03Z","timestamp":1317750543000},"page":"619-626","source":"Crossref","is-referenced-by-count":47,"title":["Preliminary Buprenorphine Sublingual Tablet Pharmacokinetic Data in Plasma, Oral Fluid, and Sweat During Treatment of Opioid-Dependent Pregnant Women"],"prefix":"10.1097","volume":"33","author":[{"given":"Marta","family":"Concheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendre\u00e9 E","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolley E","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.ftd.0000197094.92559.b4","article-title":"The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid-chromatography-electrospray ionization-tandem mass spectrometry.","volume":"28","author":"Huang","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2125.1982.tb01434.x","article-title":"Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.","volume":"13","author":"Bullingham","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of cytochrome P450 3A in n-dealkylation of buprenorphine in human liver microsomes.","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sci"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1124\/dmd.30.12.1364","article-title":"Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1.","volume":"30","author":"Rios","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1124\/dmd.109.029546","article-title":"Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.","volume":"38","author":"Rouguieg","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsat.2005.08.011","article-title":"Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.","volume":"29","author":"Chawarski","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200443050-00005","article-title":"Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone.","volume":"43","author":"Harris","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2005.08.005","article-title":"Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.","volume":"82","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/clinchem\/43.12.2292","article-title":"Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.","volume":"43","author":"Everhart","year":"1997","journal-title":"Clin Chem"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(99)00012-5","article-title":"Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet.","volume":"56","author":"Schuh","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0091270005284192","article-title":"Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials.","volume":"46","author":"Ciraulo","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0376-8716(03)00188-1","article-title":"Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naive healthy male volunteers under naltrexone block.","volume":"72","author":"McAleer","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and bussal buprenorphine.","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1360-0443.2000.95811411.x","article-title":"Treatment of opioid dependence in pregnant women.","volume":"95","author":"Fischer","year":"2000","journal-title":"Addiction"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: clinical and research issues.","volume":"35","author":"Jones","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FTD.0b013e3181d0bd68","article-title":"Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes.","volume":"32","author":"Concheiro","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1373\/clinchem.2010.154864","article-title":"Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.","volume":"57","author":"de Castro","year":"2011","journal-title":"Clin Chem"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine.","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jat\/34.8.498","article-title":"Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes.","volume":"34","author":"Concheiro","year":"2010","journal-title":"J Anal Toxicol"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.1980.124","article-title":"Renal hemodynamics and tubular function normal human pregnancy.","volume":"18","author":"Davison","year":"1980","journal-title":"Kidney Int"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women.","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1515\/jpme.1990.18.6.479","article-title":"Maternal kinetics of morphine during labour.","volume":"18","author":"Gerdin","year":"1990","journal-title":"J Perinat Med"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/sim.4780122410","article-title":"Dynamic balanced randomization for clinical trials.","volume":"12","author":"Signorini","year":"1993","journal-title":"Stat Med"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchromb.2009.11.005","article-title":"Confirmatory analysis of buprenorpine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.","volume":"878","author":"Concheiro","year":"2010","journal-title":"J Chromatogr B"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00216-010-4392-2","article-title":"Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry.","volume":"400","author":"Concheiro","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/infdis\/163.2.226","article-title":"Pharmacokinetic disposition of zidovudine during pregnancy.","volume":"163","author":"Watts","year":"1991","journal-title":"J Infect Dis"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cpt197925174","article-title":"Placental passage of oxazepam and its metabolism in mother and newborn.","volume":"25","author":"Tomson","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1373\/clinchem.2008.113712","article-title":"Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.","volume":"55","author":"Kacinko","year":"2009","journal-title":"Clin Chem"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/20.6.393","article-title":"Sweat testing in opioid users with a sweat patch.","volume":"20","author":"Kintz","year":"1996","journal-title":"J Anal Toxicol"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ADM.0b013e31815ca2c6","article-title":"Dosing adjustments in postpartum patients maintained on buprenorphine or methadone.","volume":"2","author":"Jones","year":"2008","journal-title":"J Addict Med"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e318228bb2a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:42:38Z","timestamp":1741783358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201110000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318228bb2a","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}